EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bifidobacterium lactis IDCC 4301 as a functional probiotic ingredient for body fat management in adults with overweight or obesity: A 12-week randomized, double-blind, placebo-controlled trial

Won Yeong Bang, Hyung Gyu Park, Minkyung Bok, Hyunjung Lim, Jin Seok Moon

Journal of Functional Foods · 2026-11 · 146 · 107527

DOI: 10.1016/j.jff.2026.107527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Functional Foods, 2026-11. Verfasst von Won Yeong Bang und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity-related adiposity requires safe nutritional strategies. This 12-week randomized, double-blind, placebo-controlled trial evaluated Bifidobacterium lactis IDCC 4301 (1 × 10 10 CFU/day) for body fat management in adults with a body mass index (BMI) of 25.0–29.9 kg/m 2 . Participants were randomly assigned in a 1:1 ratio to the B. lactis IDCC 4301 or placebo group using block randomization, with the randomization schedule prepared by an independent third party. In the per-protocol population ( n = 97), dual-energy X-ray absorptiometry (DEXA)-measured total fat mass changed by −735.13 ± 974.78 g in the B. lactis IDCC 4301 group and 1126.21 ± 905.79 g in the placebo group, yielding a − 1.86 kg treatment contrast ( p < 0.0001). Supportive secondary outcomes, including total body fat percentage, regional DEXA-derived fat indices, bioelectrical impedance analysis-derived fat mass, visceral fat area, body weight, BMI, waist and hip circumference, generally favored B. lactis IDCC 4301. Diet and physical activity changes did not differ between groups, and no product-related adverse events occurred. These findings may support B. lactis IDCC 4301 as a functional probiotic candidate for body fat management.

Zitieren

APA

Bang, W. Y., Park, H. G., Bok, M., Lim, H., & Moon, J. S. (2026). Bifidobacterium lactis IDCC 4301 as a functional probiotic ingredient for body fat management in adults with overweight or obesity: A 12-week randomized, double-blind, placebo-controlled trial. Journal of Functional Foods, 146, 107527. https://doi.org/10.1016/j.jff.2026.107527

Vancouver

Bang WY, Park HG, Bok M, Lim H, Moon JS. Bifidobacterium lactis IDCC 4301 as a functional probiotic ingredient for body fat management in adults with overweight or obesity: A 12-week randomized, double-blind, placebo-controlled trial. Journal of Functional Foods. 2026;146:107527. doi:10.1016/j.jff.2026.107527

BibTeX
@article{Bang2026,
  author = {Bang, Won Yeong and Park, Hyung Gyu and Bok, Minkyung and Lim, Hyunjung and Moon, Jin Seok},
  title = {Bifidobacterium lactis IDCC 4301 as a functional probiotic ingredient for body fat management in adults with overweight or obesity: A 12-week randomized, double-blind, placebo-controlled trial},
  journal = {Journal of Functional Foods},
  year = {2026},
  volume = {146},
  pages = {107527},
  doi = {10.1016/j.jff.2026.107527}
}
Kostenlos starten →